title: The art and science of switching of antipsychotic medications, part 1.
abstract: In the presentation "Prevalence of and Factors Influencing the Switching of Antipsychotic Medications," Weiden defines the recovery approach for the treatment of schizophrenia, focuses on reasons for switching antipsychotic medications, and offers recommendations for evaluating switch studies. In "Combining and Switching Medications in Bipolar Disorder," Young discusses the similarities and differences between schizophrenia and bipolar disorder, offers recommendations for switching medications in bipolar disorder, and evaluates studies of atypical antipsychotics in the treatment of bipolar disorder. Buckley's presentation, "Differential Pharmacology of Atypical Antipsychotics: Clinical Implications," examines response rates in patients with schizophrenia after switching antipsychotic medications, outlines receptor-binding profiles of atypical antipsychotics, highlights adverse events that may occur when switching antipsychotic medications, and offers recommendations for treating those adverse events.
authors.affiliation: Department of Psychiatry, Schizophrenia Research Program, State University of New York Downstate Medical Center, Brooklyn, USA.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Weiden
authors.forename: Allan H
authors.initials: AH
authors.lastname: Young
authors.forename: Peter F
authors.initials: PF
authors.lastname: Buckley
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000145:classification*; D001714:Bipolar Disorder / Q000188:drug therapy; D003072:Cognition Disorders / Q000139:chemically induced / Q000517:prevention & control; D003937:Diagnosis, Differential; D004244:Dizziness / Q000139:chemically induced / Q000517:prevention & control; D004359:Drug Therapy, Combination; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000517:prevention & control; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D019964:Mood Disorders / Q000175:diagnosis / Q000188:drug therapy; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D017211:Treatment Failure; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents